Cargando…

Influence of Npc1 genotype on the toxicity of hydroxypropyl-β-cyclodextrin, a potentially therapeutic agent, in Niemann–Pick Type C disease models()

Hydroxypropyl-β-cyclodextrin (HPBCD) is an attractive drug candidate against Niemann–Pick Type C (NPC) disease. However, the safety of HPBCD treatment for NPC patients remains to be elucidated. In this study, we examined the acute toxicity of HPBCD in Npc1-deficient mice. When treated with HPBCD (20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Yuta, Ishitsuka, Yoichi, Yamada, Yusei, Kondo, Yuki, Takeo, Toru, Nakagata, Naomi, Higashi, Taishi, Motoyama, Keiichi, Arima, Hidetoshi, Matsuo, Muneaki, Higaki, Katsumi, Ohno, Kousaku, Irie, Tetsumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121301/ https://www.ncbi.nlm.nih.gov/pubmed/27896072 http://dx.doi.org/10.1016/j.ymgmr.2013.12.003

Ejemplares similares

Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann–Pick Disease Type C Model Mice
por: Fukaura, Madoka, et al.
Publicado: (2021)

Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in Npc1-Null Cells
por: Hoque, Sanzana, et al.
Publicado: (2020)

In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C
por: Yasmin, Nushrat, et al.
Publicado: (2019)

In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease
por: Maeda, Yuki, et al.
Publicado: (2019)

Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann–Pick disease type C treatment
por: Yamada, Yusei, et al.
Publicado: (2023)

Effects of intracerebroventricular administration of 2-hydroxypropyl-β-cyclodextrin in a patient with Niemann–Pick Type C disease
por: Matsuo, Muneaki, et al.
Publicado: (2014)

Synthesis of multi-lactose-appended β-cyclodextrin and its cholesterol-lowering effects in Niemann–Pick type C disease-like HepG2 cells
por: Motoyama, Keiichi, et al.
Publicado: (2017)

Cholesterol lowering effects of mono-lactose-appended β-cyclodextrin in Niemann–Pick type C disease-like HepG2 cells
por: Motoyama, Keiichi, et al.
Publicado: (2015)

2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent
por: Yokoo, Masako, et al.
Publicado: (2015)

Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1
por: Yergey, Alfred L., et al.
Publicado: (2017)

Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1
por: Yergey, Alfred L., et al.
Publicado: (2018)

2-Hydroxypropyl-β-cyclodextrins and the Blood-Brain Barrier: Considerations for Niemann-Pick Disease Type C1
por: Calias, Pericles
Publicado: (2017)

The Effects of Combined Therapy With Metformin and Hydroxypropyl-β-Cyclodextrin in a Mouse Model of Niemann-Pick Disease Type C1
por: Du, Jiang, et al.
Publicado: (2022)

Olfactory Deficits in Niemann-Pick Type C1 (NPC1) Disease
por: Hovakimyan, Marina, et al.
Publicado: (2013)

Novel Mutation in the Feline NPC2 Gene in Cats with Niemann–Pick Disease
por: Rakib, Tofazzal Md, et al.
Publicado: (2023)

Efficacy and ototoxicity of different cyclodextrins in Niemann–Pick C disease
por: Davidson, Cristin D., et al.
Publicado: (2016)

Potential Use of Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for siRNA
por: Arima, Hidetoshi, et al.
Publicado: (2011)

Visual evoked potentials of Niemann-Pick type C1 mice reveal an impairment of the visual pathway that is rescued by 2-hydroxypropyl-ß-cyclodextrin
por: Palladino, Giampiero, et al.
Publicado: (2015)

A therapy with miglustat, 2-hydroxypropyl-ß-cyclodextrin and allopregnanolone restores splenic cholesterol homeostasis in Niemann-pick disease type C1
por: Neßlauer, Anna-Maria, et al.
Publicado: (2019)

Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for DNA, shRNA and siRNA
por: Arima, Hidetoshi, et al.
Publicado: (2012)

Pulmonary Abnormalities in Animal Models Due to Niemann-Pick Type C1 (NPC1) or C2 (NPC2) Disease
por: Roszell, Blair R., et al.
Publicado: (2013)

Hydroxypropyl-beta and -gamma cyclodextrins rescue cholesterol accumulation in Niemann–Pick C1 mutant cell via lysosome-associated membrane protein 1
por: Singhal, Ashutosh, et al.
Publicado: (2018)

Niemann-Pick C1 (NPC1)/NPC1-like1 Chimeras Define Sequences Critical for NPC1’s Function as a Filovirus Entry Receptor
por: Krishnan, Anuja, et al.
Publicado: (2012)

Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection
por: Gong, Xin, et al.
Publicado: (2016)

npc2-Deficient Zebrafish Reproduce Neurological and Inflammatory Symptoms of Niemann-Pick Type C Disease
por: Wiweger, Malgorzata, et al.
Publicado: (2021)

Understanding the phenotypic variability in Niemann-Pick disease type C (NPC): a need for precision medicine
por: Las Heras, Macarena, et al.
Publicado: (2023)

Expanded access with intravenous hydroxypropyl-β-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis
por: Hastings, Caroline, et al.
Publicado: (2019)

Folic Acid-Appended Hydroxypropyl-β-Cyclodextrin Exhibits Potent Antitumor Activity in Chronic Myeloid Leukemia Cells via Autophagic Cell Death
por: Hoshiko, Toshimi, et al.
Publicado: (2021)

Potential use of Folate-appended Methyl-β-Cyclodextrin as an Anticancer Agent
por: Onodera, Risako, et al.
Publicado: (2013)

2-Hydroxypropyl-gamma-cyclodextrin overcomes NPC1 deficiency by enhancing lysosome-ER association and autophagy
por: Singhal, Ashutosh, et al.
Publicado: (2020)

Diagnosis of Niemann-Pick disease type C with 7-ketocholesterol screening followed by NPC1/NPC2 gene mutation confirmation in Chinese patients
por: Zhang, Huiwen, et al.
Publicado: (2014)

Experience of the NPC Brazil Network with a Comprehensive Program for the Screening and Diagnosis of Niemann-Pick Disease Type C
por: Kubaski, Francyne, et al.
Publicado: (2022)

Structural Determination of Lysosphingomyelin-509 and Discovery of Novel Class Lipids from Patients with Niemann–Pick Disease Type C
por: Maekawa, Masamitsu, et al.
Publicado: (2019)

Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease
por: Collins, Christopher J., et al.
Publicado: (2017)

A phase 1/2 open label nonrandomized clinical trial of intravenous 2-hydroxypropyl-β-cyclodextrin for acute liver disease in infants with Niemann-Pick C1
por: Reynolds, Margaret, et al.
Publicado: (2021)

Pulmonary manifestations in Niemann-Pick type C disease with mutations in NPC2 gene: case report and review of literature
por: Sheth, Jayesh, et al.
Publicado: (2017)

Species-specific differences in NPC1 protein trafficking govern therapeutic response in Niemann-Pick type C disease
por: Schultz, Mark L., et al.
Publicado: (2022)

Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin
por: Kameyama, Kazuhisa, et al.
Publicado: (2017)

Preparation and evaluation of cyclodextrin polypseudorotaxane with PEGylated liposome as a sustained release drug carrier
por: Hayashida, Kayoko, et al.
Publicado: (2014)

Linear Cyclodextrin Polymer Prodrugs as Novel Therapeutics for Niemann-Pick Type C1 Disorder
por: Kulkarni, Aditya, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_376vr478g300mfbnp4t5oamemj